Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Oster

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Clinical Therapeutics|June 23, 2009
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort studyDerek Weycker, Jennifer Malin, John Kim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov modelMontserrat Vera-Llonch, Thomas E Delea, Erin Richardson, et al.
Human Vaccines & Immunotherapeutics|February 15, 2012
Clinically based surveillance of invasive meningococcal disease in young children admitted to selected US hospitals between January 2000 and June 2009: a retrospective cohort studyAriel Berger, Stephen I Pelton, Jerome O Klein, et al.
BMC Cancer|June 17, 2011
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modalityMontserrat Vera-Llonch, Derek Weycker, Andrew Glass, et al.
BMC Health Services Research|November 15, 2011
Healthcare costs in patients with metastatic lung cancer receiving chemotherapyMontserrat Vera-Llonch, Derek Weycker, Andrew Glass, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancerThomas E Delea, James McKiernan, Jane Brandman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 24, 2007
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertensionThomas E Delea, Charu Taneja, Aaron Moynahan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 28, 2020
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19Ammar Al-Chalabi, Adriano Chiò, Charlotte Merrill, et al.
The American Journal of Managed Care|January 22, 2011
Benefits and risks of live attenuated influenza vaccine in young childrenGerry Oster, Derek Weycker, John Edelsberg, et al.
The Annals of Pharmacotherapy|May 3, 2012
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorderCharu Taneja, George I Papakostas, Yonghua Jing, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Clinical Therapeutics|June 23, 2009
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort studyDerek Weycker, Jennifer Malin, John Kim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov modelMontserrat Vera-Llonch, Thomas E Delea, Erin Richardson, et al.
Human Vaccines & Immunotherapeutics|February 15, 2012
Clinically based surveillance of invasive meningococcal disease in young children admitted to selected US hospitals between January 2000 and June 2009: a retrospective cohort studyAriel Berger, Stephen I Pelton, Jerome O Klein, et al.
BMC Cancer|June 17, 2011
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modalityMontserrat Vera-Llonch, Derek Weycker, Andrew Glass, et al.
BMC Health Services Research|November 15, 2011
Healthcare costs in patients with metastatic lung cancer receiving chemotherapyMontserrat Vera-Llonch, Derek Weycker, Andrew Glass, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancerThomas E Delea, James McKiernan, Jane Brandman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 24, 2007
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertensionThomas E Delea, Charu Taneja, Aaron Moynahan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 28, 2020
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19Ammar Al-Chalabi, Adriano Chiò, Charlotte Merrill, et al.
The American Journal of Managed Care|January 22, 2011
Benefits and risks of live attenuated influenza vaccine in young childrenGerry Oster, Derek Weycker, John Edelsberg, et al.
The Annals of Pharmacotherapy|May 3, 2012
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorderCharu Taneja, George I Papakostas, Yonghua Jing, et al.
Pageof 12